Answers are grounded in this paper and cite their sources.
ES–FA–CU–GdNP drug delivery system has been developed for specific targeting in colon cancer and has the promise to address overexpressed FRs.
No takes yet. Share an insight, caveat, or question.
Khatik et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: